Panchal is set to transition to a global role within the AstraZeneca Group, based in Gaithersburg, Maryland, US. The board acknowledged his resignation and placed on record its appreciation for his ...

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

IonQ (IONQ) announced results of a research program between the company, AstraZeneca (AZN), Amazon Web Services (AMZN) and Nvidia (NVDA).

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

The AstraZeneca PLC ADR AZN rose 1.64% to $73.00 Wednesday, on what proved to be an all-around mixed trading session for the ...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...

Dr. Tasso Milliotis, Principal Scientist at AstraZeneca, has already experienced the remarkable benefits of these new columns: ...

Butterfly Network, Inc. (NYSE: BFLY) delivered strong Q1 results with $21.2 million in revenue, up 20% from the prior year, ...

AstraZeneca PLC (NASDAQ:AZN – Free Report) – Stock analysts at Zacks Research lowered their Q2 ... focuses on the discovery, development, manufacture, and commercialization of prescription ...

These investments have also included the expansion of AstraZeneca’s Global Research and Development (R&D) Hub and the creation of a new Alexion R&D Hub focused on rare disease research. With a 70-year ...

"We are also expanding our presence in the United States with significant investments in research, development and manufacturing," said Pascal Soriot, AstraZeneca’s Chief Executive Officer.